MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 29.74 million. The enterprise value is 18.88 million.

Market Cap	29.74M
Enterprise Value	18.88M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

MediPharm Labs has 424.86 million shares outstanding. The number of shares has increased by 4.10% in one year.

Current Share Class	424.86M
Shares Outstanding	424.86M
Shares Change (YoY)	+4.10%
Shares Change (QoQ)	+1.30%
Owned by Insiders (%)	9.16%
Owned by Institutions (%)	0.00%
Float	385.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	0.79
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.35
EV / Sales	0.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.64

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.01.

Current Ratio	3.20
Quick Ratio	2.18
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-101.18

Financial Efficiency

Return on equity (ROE) is -19.36% and return on invested capital (ROIC) is -9.79%.

Return on Equity (ROE)	-19.36%
Return on Assets (ROA)	-8.03%
Return on Invested Capital (ROIC)	-9.79%
Return on Capital Employed (ROCE)	-17.37%
Revenue Per Employee	286,360
Profits Per Employee	-49,845
Employee Count	161
Asset Turnover	0.90
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.71
52-Week Price Change	n/a
50-Day Moving Average	0.07
200-Day Moving Average	0.07
Relative Strength Index (RSI)	49.69
Average Volume (20 Days)	258,333

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 46.10 million and -8.03 million in losses. Loss per share was -0.02.

Revenue	46.10M
Gross Profit	13.96M
Operating Income	-6.58M
Pretax Income	-8.03M
Net Income	-8.03M
EBITDA	-4.84M
EBIT	-6.58M
Loss Per Share	-0.02

Balance Sheet

The company has 11.28 million in cash and 423,000 in debt, with a net cash position of 10.86 million or 0.03 per share.

Cash & Cash Equivalents	11.28M
Total Debt	423,000
Net Cash	10.86M
Net Cash Per Share	0.03
Equity (Book Value)	37.86M
Book Value Per Share	0.09
Working Capital	19.19M

Cash Flow

In the last 12 months, operating cash flow was -7.01 million and capital expenditures -144,000, giving a free cash flow of -7.15 million.

Operating Cash Flow	-7.01M
Capital Expenditures	-144,000
Free Cash Flow	-7.15M
FCF Per Share	-0.02

Margins

Gross margin is 30.28%, with operating and profit margins of -14.27% and -17.41%.

Gross Margin	30.28%
Operating Margin	-14.27%
Pretax Margin	-17.41%
Profit Margin	-17.41%
EBITDA Margin	-10.50%
EBIT Margin	-14.27%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.10%
Shareholder Yield	-4.10%
Earnings Yield	-26.98%
FCF Yield	-24.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.52
Piotroski F-Score	2